The seventh webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on rectal microbicides. The presentation was followed by a Q&A session.
Avac Event
HIV Prevention Europe Webinars: Rectal microbicides
Avac Event
Risky Women: Disrupting simple notions of women’s HIV risk
The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.
Avac Event
How to Communicate about Sexual Health and STIs: Sex positivity vs. risk-based language
Thursday, April 20 at 9:30 AM – 11:00 AM ET
Join The Choice Agenda for a conversation focused on sex positivity and risk-based language when discussing sexual health and STIs.
Speakers include Dr. Keosha T. Bond, CUNY School of Medicine, Dr. Joseph Cherabie, Washington University St. Louis, Mark Kaigwa, Nendo, and moderated Alison Footman, AVAC
Webinar co-sponsored by the American Sexual Health Association.
Click here to convert the time to your location.
This webinar is a part of The Choice Agenda.
Avac Event
Global PPPR Equity: Why do we need agreements on IP and tech transfers?
April 6, 2023, 9:00AM Washington/2:00PM London/4:00PM Nairobi
Over the past two decades, HIV advocates have engaged in hard battles for equitable access to HIV/AIDS drugs and prevention options and have had some big wins. The process of these negotiations has led to strong relationships that have enshrined certain equity provisions as standard in clinical trials and manufacturing of HIV drugs. Through these battles, we’ve learned clear lessons on the necessity for such agreements and what’s required to secure them.
Throughout global PPPR agreements in 2023, governments and advocates in the Global South are asking for provisions on equity in the form of temporary IP waivers, mandatory tech transfer, and mandatory licensing for pandemic tools.
This panel will discuss lessons from the HIV epidemic and explore why governments of the Global South and advocates think we still need to address ‘the IP question’.
Featured Speakers: Fifa Rahman, Brook Baker, Fitsum Lakew, and moderated by Samantha Rick, AVAC
Avac Event
PrEP That Booty: The latest on rectal microbicide research for the back door
Thursday, June 29 at 9:00 AM–10:30AM ET
Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver. However, these attributes are not desirable to many folks, and communities want a range of choices. Researchers and advocates for years have been working on HIV prevention products specifically for the back door (rectum) to provide protection during anal intercourse. These products are user-controlled, non-systemic (the drug stays in the booty and only the booty), and are short-acting, so you don’t have to commit to having a prevention drug in your body for a year or longer. Join us for a dynamic discussion regarding the latest research on Booty PrEP – aka rectal microbicides – with our multi-talented panel.
Speakers include: Jonathan Baker, PA, Laser Surgery Care, Dr. Craig Hendrix, Johns Hopkins, Juan Michael Porter II, The Body, and Dr. Sharon Riddler, University of Pittsburgh
Avac Event
PrEP (In)equity: Documenting, measuring, and flipping the script towards justice
Tuesday, May 9 at 9:00 AM–10:30AM ET
Disparities in PrEP awareness, access, and uptake are stark in the United States, and play out along lines of race, gender, age, and geography. While we see increases in PrEP uptake overall, these metrics tend to mask the fact that the people who most need PrEP are not to be found in those numbers. As we see new modes of PrEP delivery become available, we are concerned these “shiny new things” will be yet another way to measure disparities and not actually help those who most need it. We must focus on these inequities with laser-like intensity, allocate resources using an equity model, and strive harder for PrEP justice.
Speakers include: Leisha-McKinley Beach, National HIV/AIDS Consultant, Michael Chancley, PrEP4All, and Dr. Patrick Sullivan, Emory
Avac Event
HIV Prevention Plus Plus: Developing Options that Meet the Full Range of our Sexual and Reproductive Health Needs
Tuesday, April 25 at 9:00 AM–10:30AM ET
Despite a dynamic research and development (R&D) pipeline for prevention products, male and female condoms remain the only multi-purpose prevention technologies (MPTs) currently available. Yet MPTs are an integral part of the HIV prevention advocacy agenda. For decades, advocates have pushed for products to be developed that simultaneously prevent HIV, other sexually transmitted infections (STIs) and/or pregnancy.
With a growing number of PrEP options already, what will it take to bring a new MPT to market? A Dual Prevention Pill (DPP – https://www.prepwatch.org/products/dual-prevention-pill/) that prevents both HIV and pregnancy could be just two years away. Looking further upstream, there are over 25 other MPTs in the pipeline (https://www.prepwatch.org/research-pipeline/), including vaginal rings, which would follow in the footsteps of the dapivirine vaginal ring recommended by WHO and recently approved in several countries.
Within this fast-evolving HIV prevention landscape, work is already underway to build a platform to introduce the DPP, which could speed up the rollout of other MPTs. Join us to hear what we’ve learned so far on R&D, marketing, counseling and delivery for MPTs – and to discuss what we can do now to prepare prevention markets to include new MPT options.
Featured Speakers:
Ruth Akulu, ICWEA, AVAC fellow
Barbara Friedland, Population Council
Gregorio Millet, amfAR
Dr. Thesla Palanee-Phillips, Wits RHI
Danielle Resar, Clinton Health Access Initiative
Co-moderators: Wawira Nyagah, AVAC Kate Segal, AVAC
This webinar is a part of The Choice Agenda.
Avac Event
DRM Learning Collaborative
Thursday, April 6, 15.00hours to 16.30hours (EAT)/8:00-9:30am (EST)
Welcome to this year’s first meeting of the Domestic Resource Mobilization learning collaborative. The Learning Collaborative is a virtual space that brings together global health advocates, civil society organizations and other key stakeholders from Africa to engage in peer-to-peer learning and partner in advocacy for a sustainably funded health R&D and infrastructure in Africa.
The upcoming learning collaborative meeting take place on Thursday April 6th, from 15.00hours to 16.30hours (EAT)/8:00-9:30am (EST). The focus will be on the need to invest in local vaccine manufacturing in Africa. We will discuss the landscape including challenges and opportunities, and identify priority advocacy towards expanding local manufacture of vaccines, diagnostics, and therapeutics.
Avac Event
Mpox – Sexual Networks, HIV and Activism
Wednesday, March 29 at 9:30–11:00am ET
MPX NYC: A community-led study on queer sex in New York City
Dr. Keletso Makofane, Harvard University, FXB Health & Human Rights Fellow
Mpox and HIV
Dr. Chloe Orkin, Professor of HIV Medicine, Queen Mary University of London
This webinar is a part of The Choice Agenda.
Avac Event
When Cure Means Control
An introduction to viral control off therapy
Tuesday, March 28 at 9:00 am ET
As the number of cure-related clinical trials grows, so does the number of people experiencing month-long delays in viral rebound. A very small handful of participants remain off therapy long after the trial ends. These individuals who can control HIV without therapy after an intervention are known as controllers.
This webinar will:
- Introduce the concept of viral control off therapy
- Provide a platform to ask experts questions on HIV control
- Introduce key issues advocates should be following
Featuring Jon LI, Harvard University; Marina Caskey, Rockefeller University; Ann Chahroudi, Emory School of Medicine, Josephine Nabukenya, EGPAF Board Member and IAS Governing Council Member, and moderated by Jessica Salzwedel, AVAC